Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Pituitary

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Pituitary|August 24, 2022
Special issue: Cushing's disease updateMaria Fleseriu
Pituitary|December 17, 2010
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature reviewMaria Fleseriu
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Pituitary|March 4, 2017
Acromegaly, a pituitary special issueMaria Fleseriu, Monica Gadelha
Pituitary|June 8, 2012
Medical management of Cushing's disease: what is the future?Maria Fleseriu, Stephan Petersenn
Pituitary|May 31, 2024
Acromegaly and COVID-19, lessons, and new opportunitiesElena V Varlamov, Maria Fleseriu
Pituitary|February 3, 2019
Response to letter to the editor from Professor Jean-François BonnevilleLisa B Nachtigall, Maria Fleseriu
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Pituitary|August 24, 2022
Special issue: Cushing's disease updateMaria Fleseriu
Pituitary|December 17, 2010
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature reviewMaria Fleseriu
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Pituitary|March 4, 2017
Acromegaly, a pituitary special issueMaria Fleseriu, Monica Gadelha
Pituitary|June 8, 2012
Medical management of Cushing's disease: what is the future?Maria Fleseriu, Stephan Petersenn
Pituitary|May 31, 2024
Acromegaly and COVID-19, lessons, and new opportunitiesElena V Varlamov, Maria Fleseriu
Pituitary|February 3, 2019
Response to letter to the editor from Professor Jean-François BonnevilleLisa B Nachtigall, Maria Fleseriu
Pageof 7